Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 15, 2010

Premium

Prosolia this week named Justin Wiseman president and CEO. Chairman Peter Kissinger has stepped down from his role as interim CEO, and former president Kevin Boscacci has resigned his position and left the company.

Wiseman was previously Prosolia's research director and has been involved with the company since it launched in 2004.

The board of directors also elected John Hertig as a member. Hertig is the executive director of AMIPurdue.


Peter Lewis was appointed this week vice president of finance and administration at Bioscale.

Before joining Bioscale, Lewis worked with Affymetrix, First Boston Pharma, PerkinElmer, and Intron.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.